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The 1996 Safe Drinking Water Act Amendments (1) mandate that the EPA revise the current drinking water standard for arsenic of 50 pg/liter (ppb) by the year 2000. Cross-sectional studies conducted in Taiwan in the late 1960s (2, 3) reported associations with blackfoot disease, a vaso-occlusive disorder that has never been reported in U.S. populations, and skin cancer. Previous studies of arsenic in drinking water in the United States have evaluated nonmelanoma skin cancer (4) (5) (6) (7) (8) , bladder cancer (9), vascular disease (10) , reproductive effects (11, 12) , and toxic effects (13) (14) (15) . The results from these studies have been mostly negative. In a review of U.S. skin cancer prevalence studies (16) , populations with adequate exposure and health outcome data had drinking water arsenic concentrations of <500 ppb. In contrast, studies in other countries have indicated associations with much higher concentrations of arsenic in drinking water supplies and a wide range of health effects, including a variety of cardiovascular effects, diabetes mellitus, and cancer other than skin cancer. Other investigators in the United States have presented analyses that suggest larger and more comprehensive U.S. studies are possible (9, 10) .
In the late 1970s the EPA conducted a small study in Millard County, Utah, on a population exposed to drinking water with a mean arsenic concentration of at least 150 ppb (range 53-750 ppb). To conduct a mortality study, we established a cohort of Millard County residents based on the 1 970s-era studies. The objective of the current study was to examine the health effects of chronic consumption of arseniccontaminated drinking water in a U.S. population. This paper describes the results of an analysis of drinking water arsenic exposures of <200 ppb and cancer and noncancer health effects in a U.S. population. Results on both cancer and noncancer causes of death are presented, along with drinking water arsenic exposure concentrations that consider residence time in the geographic study area.
Materials and Methods
Cohort assembly. The cohort was assembled from historical ward membership records of the Church of Jesus Christ of Latter-day Saints (LDS) (also known as the Mormons). These records represent the registry of all members who ever lived in a ward during a specific time period. The registers were compiled by ward members. An LDS church ward is a defined geographic area whose residents constitute a single congregation. In this study, the boundaries of the LDS church wards are closely aligned with their respective town boundaries. The wards and years for which the historical membership books were kept, which were used in constructing the cohort (i.e., enrolling the cohort members), include 1) Delta for the years [1921] [1922] [1923] [1924] (17) .
All death certificates were verified to ensure a match on identity, gender, and date of birth as compared to the abstracted information from the historic ward membership files. Quality control review of the underlying cause of death was performed on 10% of death certificates from the initial phase of the cohort study by a first nosologist. Cause-of-death codes that were in question were submitted to a second nosologist at the National Center for Health Statistics (Research Triangle Park, NC), who verified the coding of the first nosologist. All death certificates collected in the most recent enrollment were verified for ICD-9 coding by the first nosologist. The corrected codes were entered into the database and used in the analysis.
Water samples. Community drinking water arsenic concentrations were determined by historical records of arsenic measurements in drinking water maintained by the state of Utah dating back to 1964.
An overview of arsenic concentrations in drinking water and source-of-exposure information for the study area were presented in a previous feasibility assessment (18) . In the current study, arsenic exposure levels for the communities were based on measurements performed by the Utah State Health Laboratory (Salt Lake City, UT), which participated in the EPA's quality assurance program and water quality proficiency testing. In addition, the samples must have originated from a water source used for culinary or potable purposes (not for agricultural or irrigation purposes), and the location of the source of the water sample (i.e., community) had to be clearly identified. The analysis date must have been 1976 or later, when the sample collection method involved acidification of the collection containers. This resulted in 151 samples of drinking water that were used in assessing the potential exposure of cohort members to arsenic in drinking water. The distribution of the concentrations of arsenic in drinking water in the study communities is provided in Table 1 The arsenic exposure index scores are expressed as ppb-years and are calculated as follows:
E. = X(D x A) = ppb-years where E = exposure index score value for individual i in ppb-years, D = duration of residence in years in community x for individual i, and A = median arsenic concentration in drinking water for community x in ppb.
The arsenic exposure index was categorized as low (<1,000 ppb-years), medium (1,000-4,999 ppb-years), and high (>5,000 ppb-years). The rationale for this categorization is that 20 years ofexposure is a reasonable Volume 107, Number 5, May 1999 * Environmental Health Perspectivesperiod for most cancers to become manifest and an exposure to drinking water with 50 ppb arsenic or higher will yield a cumulative arsenic exposure of 1,000 ppb-years.
Analysis. Basic distributions of selected variables were made using SAS statistical software (21) . The cohort data analysis uses standardized mortality ratios (SMRs) as the measure of association (22) . The OCMAP program (23) , adapted to a nonoccupational cohort, was used to compare the observed number of deaths with the expected number of deaths generated from death rates from the white male and white female general population of Utah within a given underlying cause of death category. Because a review of the race variable entered on the death certificates showed that all deceased individuals were white, death rates for white males and white females were used. To assess whether an increased exposure to drinking water arsenic could affect (10, 19, 20, 29, 36) , diabetes mellitus water exposures that can exceed 2,000 ppb.
water. In general, the highest exposures in (34, 37, 38) , and potentially neurologic effects Although the Taiwan studies (2,3) U.S. studies are similar to the lowest expo- (7, 39) The major strength of this study is that it examines the effects of chronic exposure to arsenic in a U.S. population. Advantages of the cohort design include that the exposure precedes the effect, and that cohort studies have the capability to provide information on a variety of health effects from a single exposure (22) . While the exposure is ecologic, i.e., not tied to an individual's actual consumption, the arsenic exposure estimates are believed to be accurate and the exposure is believed to have remained constant over time. During this study, the investigators were able to gather a considerable number of arsenic concentrations from private wells, so that estimates of exposure to arsenic from drinking water for individuals may be possible in future studies. Although individual data on confounding factors are not available, the historic membership of the cohort in the LDS church permits some assumptions regarding personal lifestyle including prohibition of tobacco use and of the consumption of alcohol or caffeine. Because church policy dictates that membership registration records are placed in the church ward of a member's residence, there is a high degree of confidence that the cohort members were exposed to the concentrations of drinking water arsenic for the communities in which they resided. Although the period of residence in the study area for the cohort members exceeds the period of available exposure information, historical documents indicate that drinking water quality has not changed considerably because of 100% reliance on groundwater supplies (18 (19) , arteriosderosis (29) , cerebrovascular disease (36) , ischemic heart disease (20) , and other vascular diseases (10, 35, 43) , have been reported. It has been hypothesized that exposure to arsenic in drinking water may be directly linked to ischemic heart disease and blackfoot disease via the atherogenic pathway (44) . Indirect effects of arsenic on other cardiovascular risk factors including hypertension and diabetes (19, 36) have also been proposed. Arsenic has been associated with vascular lesions including angiosarcomas and atherosclerotic plaques, suggesting that arsenic plays a role in somatic mutations and cell proliferation in the etiology of atherosclerotic plaques (45) . In the current study, increased associations for hypertension and arteriosclerosis were found for both males and females. Death from all other heart disease in females was increased. This category included pulmonary heart disease, pericarditis, and other diseases of the pericardium.
The findings of cardiovascular effects in the context of a dose-response relationship with drinking water arsenic in this analysis are less clear. Although SMRs cannot be directly compared in an analysis that uses indirect adjustment, trends may be observed if the age and gender distributions in the exposure groups are similar. In Table  2 , the age distributions are not similar (chisquare = 48.4, 8 degrees of freedom, p<0.01), but the gender distributions are similar (chi-square = 1.9, 2 degrees of freedom, p = 0.17). Based on this, any conclusions on whether arsenic is an etiologic factor in consideration of increased or decreased SMRs among the groups is uncertain. Further evaluation of the relationship of each of these cardiovascular diseases with drinking water arsenic in this and other populations is needed. Positive associations with diabetes mellitus and the concentration of arsenic in drinking water have been reported in India, Bangladesh, and Argentina (34, 37, 38) . In this study, there is no clear indication of any relationship between the concentration of arsenic in drinking water and diabetes mellitus.
Associations for nonmalignant respiratory diseases and bronchitis, emphysema, and asthma combined were also decreased, possibly indicating that the respiratory health of the cohort was good and smoking was not a major factor. Death from respiratory cancers was decreased significantly for both males and females. Because the cohort was assembled based on historic LDS records, it is believed that the cohort was largely nonsmoking, as smoking is prohibited by the LDS church. (9, 32, 33, 35) and an ecologic study in Argentina (26) have reported associations for increased exposure to drinking water arsenic and risk for bladder cancer. A case-control study of bladder cancer in Utah (9) did not find an association with ingested arsenic, and in the Millard County mortality study only five deaths were due to bladder cancer. Whereas the studies in Taiwan and Argentina reported high exposures to drinking water arsenic, this study population was exposed to much lower levels, perhaps indicating that bladder cancer occurs in response to higher arsenic concentrations. In reviewing other causes of death from the urinary system, death from kidney cancer and nephritis and nephrosis were consistently elevated in both males and females. However, the SMRs did not increase with increasing levels of exposure. Other subclassifications of the types of nephritis and nephrosis were not available for the analysis, but competing causes such as infections need to be ruled out.
An increase in mortality due to melanoma in the lowest exposure category was found among females. Although skin cancer is etiologically linked with arsenic in drinking water, melanoma is not the histologic type of skin cancer usually associated with arsenic intake (54) . In females, all of the melanoma deaths occurred in the lowest exposure category where the expected number was less than one. Based on these small numbers, it is not possible to draw conclusions about any involvement of exposure to arsenic in drinking water with this finding. Alternatively, continued follow-up of the cohort in the future could clarify whether the association between arsenic exposure and melanoma disappears. In contrast, the results for melanoma among males were negative.
Based on these cohort data, we do not believe that loss to follow-up, confounding, or multiple comparisons played a significant role in these results. Based on their review of several cohort studies, Breslow and Day (55) noted that loss to follow-up is acceptable if it is < 10%. Our loss to follow-up is 7.4%. The distribution of this group by drinking water arsenic exposure was 163 in the low-exposure group, 96 in the medium-exposure group, and 41 in the high-exposure group. Because the net effect of loss to follow-up is to bias results toward the null value (55) , and because most of the loss to follow-up is already in the low group in this cohort, the impact on our results would be to attenuate any observed effects rather than to spuriously increase them.
In this study, potential exposure to atmospheric arsenic is the most likely confounder because this variable is related both to health effects in previous studies of miners (56, 57) and is associated with availability in sediments as a result of mining (58) . Although data on atmospheric arsenic concentration was sought from the state of Utah to address potential confounding effects from this alternate exposure to arsenic, this type of data is not routinely collected. However, future studies involving arsenic exposure assessment will consider atmospheric arsenic data collection. Because the study region in Millard County is primarily agricultural or vast desert with no mining activity, we do not believe a significant part of the exposure to arsenic was due to atmospheric exposure.
Because most of the significant associations we found in this analysis have been found by others and were not unanticipated, we do not believe multiple comparisons of exposure and outcome in these data represent a problem. To adjust for multiple comparisons would be incorrect because the correction theory is based on the universal null hypothesis that chance serves as the explanation for observed associations (59) . Associations with hypertension and prostate cancer have been reported elsewhere (19, 35) . The association with nephritis and nephrosis is worthy of further investigation. Human autopsy data do not suggest arsenic accumulates more in the kidney than in other internal tissues (60, 61) . Although it is unknown whether the kidney represents a site of injury of arsenic, arsenate has been taken up by the phosphate carrier in cells of the proximal convoluted tubule (62) .
In conclusion, this study represents a unique opportunity for health researchers to better understand the potential for health effects in association with relatively low exposure to arsenic in drinking water in a U.S. population. Although cohort members contributed many years to the highly exposed group and some died at an advanced age with no perceived adverse effects, further examination of this cohort is planned. Additional analysis of the data continues and includes a Cox proportional hazards analysis that will allow internal comparisons to be made between high, medium, and low exposure categories. Results from this study are important in the context of the ongoing review of the U.S. drinking water arsenic standard. This study will provide some insight into the role of both noncarcinogenic end points and carcinogenic end points in the review of the drinking water arsenic standard. Data from this cohort study will be especially useful in evaluating hazard identification and will provide some information on potential dose-response relationships as specified in the risk assessment paradigm.
